Search

iStent Inject With Premium IOL Implantation

Inder Paul Singh, MD

Show Description +

Inder Paul Singh, MD, demonstrates use of the iStent inject (Glaukos) following implantation of a Trulign Toric lens (Bausch + Lomb) and explains that use of this MIGS device does not impact the predicability of refractive measurements. This patient was on two medications preoperatively with an IOP of 18 mmHg and was 14 mmHg with 20/25 vision one day postoperatively.

Posted: 3/21/2019

Keywords:

Glaukos Corporation

•

Inder Paul Singh, MD

•

iStent

•

iStent Inject

•

Microinvasive Glaucoma Surgery (MIGS)

•

Microinvasive Glaucoma Surgery (MIGS)

•

Premium IOLs

Up Next

FLACS With Toric and iStent inject

FLACS With Toric and iStent inject

Blake Williamson, MD, MPH, MS

Targeted Placement of iStent Trabecular Micro-Bypass Stent (Glaukos)

Targeted Placement of iStent Trabecular Micro-Bypass Stent (Glaukos)

Eric Rosenberg, MD

Cataract Surgery Combined with Canaloplasty

Cataract Surgery Combined with Canaloplasty

Mahmoud A. Khaimi, MD

Needle Viscocanalostomy

Needle Viscocanalostomy

Eslam Ramadan, MD

Ahmed M4 Placement

Ahmed M4 Placement

Nathan Radcliffe MD

Hydrogel Sealant to Prevent Chamber Shallowing During Combined Phaco and Tube Shunt Insertion

Hydrogel Sealant to Prevent Chamber Shallowing During Combined Phaco and Tube Shunt Insertion

Ian Conner, MD

Supra-Tenons Baerveldt Glaucoma Drainage Device

Supra-Tenons Baerveldt Glaucoma Drainage Device

George Tanaka, MD

iStent Trabecular Microbypass Implantation Technique

iStent Trabecular Microbypass Implantation Technique

Ike K. Ahmed MD

Trabectome 180

Trabectome 180

Constance Okeke, MD, MSCE

New Directions for GT

New Directions for GT

Arsham Sheybani, MD, Iqbal Ike K. Ahmed, MD, FRCSC

iStent Inject With Premium IOL Implantation

Inder Paul Singh, MD

Inder Paul Singh, MD, demonstrates use of the iStent inject (Glaukos) following implantation of a Trulign Toric lens (Bausch + Lomb) and explains that use of this MIGS device does not impact the predicability of refractive measurements. This patient was on two medications preoperatively with an IOP of 18 mmHg and was 14 mmHg with 20/25 vision one day postoperatively.

Posted: 3/21/2019

Keywords:

Glaukos Corporation

•

Inder Paul Singh, MD

•

iStent

•

iStent Inject

•

Microinvasive Glaucoma Surgery (MIGS)

•

Microinvasive Glaucoma Surgery (MIGS)

•

Premium IOLs

Please log in to leave a comment.

More in Glaucoma

Implementing Interventional Glaucoma Treatment Protocols

Implementing Interventional Glaucoma Treatment Protocols

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD

Treatment Patterns and Patient Compliance

Treatment Patterns and Patient Compliance

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; and Deborah Ristvedt, DO

Practice Assessment Results

Practice Assessment Results

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD

The Unmet Need for a Consensus Treatment Approach to Glaucoma

The Unmet Need for a Consensus Treatment Approach to Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD